6.81
-0.13(-1.87%)
Currency In USD
| Previous Close | 6.94 |
| Open | 6.84 |
| Day High | 7.15 |
| Day Low | 6.75 |
| 52-Week High | 10.85 |
| 52-Week Low | 1.03 |
| Volume | 1.71M |
| Average Volume | 2.07M |
| Market Cap | 757.68M |
| PE | -5.16 |
| EPS | -1.32 |
| Moving Average 50 Days | 6.47 |
| Moving Average 200 Days | 3.58 |
| Change | -0.13 |
If you invested $1000 in Tango Therapeutics, Inc. (TNGX) since IPO date, it would be worth $665.69 as of September 09, 2025 at a share price of $6.81. Whereas If you bought $1000 worth of Tango Therapeutics, Inc. (TNGX) shares 3 years ago, it would be worth $1,825.74 as of September 09, 2025 at a share price of $6.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 11:00 AM GMT
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Can
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
GlobeNewswire Inc.
Jul 22, 2025 11:00 AM GMT
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not inte
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer
GlobeNewswire Inc.
Jun 27, 2025 11:00 AM GMT
BOSTON, June 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been do